TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 45 filers reported holding TFF PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $162,000 | -28.3% | 40,013 | 0.0% | 0.77% | -29.6% |
| Q2 2022 | $226,000 | -10.7% | 40,013 | -0.3% | 1.09% | +28.1% |
| Q1 2022 | $253,000 | -28.7% | 40,119 | +0.3% | 0.85% | -16.7% |
| Q4 2021 | $355,000 | +14.9% | 40,005 | 0.0% | 1.02% | +12.7% |
| Q3 2021 | $309,000 | +17.5% | 40,005 | +46.4% | 0.91% | +35.3% |
| Q2 2021 | $263,000 | -28.7% | 27,323 | +0.4% | 0.67% | -33.0% |
| Q1 2021 | $369,000 | -99.9% | 27,216 | -2.7% | 1.00% | -20.8% |
| Q4 2020 | $400,430,000 | +61982.2% | 27,963 | -19.9% | 1.27% | -54.2% |
| Q3 2020 | $645,000 | +106.1% | 34,902 | -35.7% | 2.76% | +87.6% |
| Q2 2020 | $313,000 | +46.3% | 54,264 | -2.7% | 1.47% | +9.3% |
| Q1 2020 | $214,000 | -35.9% | 55,745 | -10.8% | 1.35% | -4.4% |
| Q4 2019 | $334,000 | – | 62,503 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |